Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
about
RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancerHigh-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix compositionSMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cellsDifferential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer.TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5).SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathwayGene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancerThe role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II).Advances in biomarker research for pancreatic cancer.Development and progression of colorectal neoplasia.DPC4 expression in the small intestinal adenocarcinomas.Transforming growth factor-beta in cancer and metastasis.Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanaseUp-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer.Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection.Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.SMAD4 and its role in pancreatic cancer.Smad4 deficiency in cervical carcinoma cells.Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.Genetic mutations in human rectal cancers detected by targeted sequencing.Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance.Smad4 inactivation promotes malignancy and drug resistance of colon cancer.Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.Frequent loss of SMAD4/DPC4 protein in colorectal cancers.Frequent loss of SMAD4/DPC4 protein in colorectal cancers.Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients.The role of TGF-β/SMAD4 signaling in cancer.Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.
P2860
Q21134105-F3140DDD-FE15-4344-B093-BF482AA1B475Q24683692-4C54EFBA-9345-4062-A91E-2094D504D64DQ27851475-4C3D832D-D443-4FF6-9172-B5F0A9F39807Q33210191-4796ABBB-172D-4276-8E25-AE6F4A2A6EA3Q33215713-A3EDD951-6EF9-4965-9EF4-6303B405062FQ33293871-DD200569-0982-49FC-B0A5-C57E54BB9A9EQ33355827-4218A790-034C-46BD-9EB3-396A86F482A2Q33933528-BBC1CE32-E405-4503-A301-8FFD3676BA92Q34084819-F7A730A2-5DCE-4107-A576-10F24A6D58B3Q35190834-6C8928A1-25EA-4CA4-8CE7-92FA802EF347Q35218771-A005D1D1-1C19-4C9A-925A-592A22EB24BCQ35774267-79B3A207-4C81-42A3-B57A-0D821F32DED8Q35969342-19E188C2-CAEF-4997-BF70-E0E75AAFD4E2Q36126609-7E57424F-C062-48C3-9643-BE5E7F5CEB35Q36241935-4CC32698-A3F4-491D-901F-D4F47ADBF12FQ36374593-AA57664D-E9A6-490A-ABAA-E50A70A28FD7Q36585129-015127A2-7C68-4B66-8E3E-1E9CC00A9896Q36612507-58EB529F-A832-4E1F-A0CD-62360ED2E25AQ36685492-5527DD41-ECB7-467A-9303-B35B1B3740B0Q37232636-885331F9-720F-4895-9B74-BBF056C2773FQ37320486-691ECEA2-637B-46A6-A443-DD3C19DC0E4AQ37386625-A0E75BBC-08DB-4F42-9FCA-B14842AC18DFQ37746284-FAC20F75-8B2F-4BFE-AEC5-8F336D3850C6Q38281261-BFE00BFA-C9C8-446F-86F5-26F634DBA805Q38334502-9B1F3EA8-5E22-4339-BA52-292F73DE78EFQ38484441-AC645FE7-9FA1-4489-968C-3BEBCCC580EAQ38989186-A2B2FD12-6F5A-453B-9D55-C62414518E52Q38994193-B10CBCCB-BAC3-4C1D-BBE5-AD7C339411BAQ39076794-66A3BEB5-1B70-428D-BD8A-A4E615BF9D1BQ39606293-F191BEAA-A3B3-4241-9C5A-FDDA93EC7D96Q40235611-3BF171D3-A938-4361-A5C8-646DBFA75364Q40473801-D29D96D5-020D-4F32-9B84-83A189D5C090Q43006283-552E1BAE-5083-4278-937F-E0677F3A98A3Q46967621-E61F1AD5-321A-42BA-BC19-9272DE972C8BQ50199064-800DF353-11D4-4E43-A1BB-D33FBE5961B2Q52688883-B7C8F5CF-77AC-48D5-9F40-5D06071BFCC6Q54650116-A06439C2-764A-4BF9-9502-29A0179A97D1
P2860
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@ast
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@en
type
label
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@ast
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@en
prefLabel
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@ast
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@en
P2093
P2860
P1476
Loss of Dpc4 expression in col ...... resence of metastatic disease.
@en
P2093
Albores-Saavedra J
Lindberg G
P2860
P304
P356
10.1016/S0002-9440(10)64625-1
P407
P577
2000-10-01T00:00:00Z